Rocket Pharmaceuticals (RCKT)
Develops gene therapies for rare immune and cardiovascular disorders.
$3.43
After-hours close+0.08 (+2.24%)
At close$3.36(+2.60%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 44 days
EPS estimate
−$0.39
Revenue estimate
$200.0K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.62−$0.56−$0.59−$0.45−$0.38−$0.42$1.08Pending
Estimate−$0.68−$0.59−$0.57−$0.48−$0.42−$0.41$0.86−$0.39
Surprise+8.8%+5.1%−3.5%+6.2%+9.5%−2.4%+25.6%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported———————Pending
Estimate$28.5K$800.0K$4.4M$312.5K$277.8K$4.5M$18.2M$200.0K
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.38 | — | — |
| Sep 2027 | −$0.39 | — | — |
| Jun 2027 | −$0.38 | — | — |
| Mar 2027 | −$0.38 | — | — |
| Dec 2026 | −$0.41 | — | — |
| Nov 2026 | −$0.39 | — | — |
| Aug 2026 | $0.86 | $1.08 | +25.6% |
| May 2026 | −$0.41 | −$0.42 | −2.4% |
| Feb 2026 | −$0.42 | −$0.38 | +9.5% |
| Nov 2025 | −$0.48 | −$0.45 | +6.2% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.38 | — | — | $5.2M | — | — | — |
| Sep 2027 | −$0.39 | — | — | $4.5M | — | — | — |
| Jun 2027 | −$0.38 | — | — | $3.7M | — | — | — |
| Mar 2027 | −$0.38 | — | — | $3.2M | — | — | — |
| Dec 2026 | −$0.41 | — | — | $687.1K | — | — | — |
| Nov 5, 2026 | −$0.39 | — | — | $200.0K | — | — | — |
| Aug 10, 2026 | $0.86 | $1.08 | +25.6% | $18.2M | — | — | −3.9% |
| May 7, 2026 | −$0.41 | −$0.42 | −2.4% | $4.5M | — | — | −4.9% |
| Feb 26, 2026 | −$0.42 | −$0.38 | +9.5% | $277.8K | — | — | +4.6% |
| Nov 6, 2025 | −$0.48 | −$0.45 | +6.2% | $312.5K | — | — | −2.7% |
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 5, 2024 | |||||||
| May 6, 2024 | |||||||
| Feb 26, 2024 | |||||||
| Nov 6, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 4, 2023 | |||||||
| Feb 27, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 5, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 3, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 10, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Nov 4, 2020 | |||||||
| Aug 5, 2020 | |||||||
| May 6, 2020 | |||||||
| Mar 5, 2020 | |||||||
| Nov 7, 2019 | |||||||
| Aug 7, 2019 | |||||||
| May 8, 2019 | |||||||
| Mar 7, 2019 | |||||||
| Nov 7, 2018 | |||||||
| Aug 8, 2018 | |||||||
| May 11, 2018 | |||||||
| Mar 7, 2018 | |||||||
| Nov 8, 2017 | |||||||
| Aug 3, 2017 | |||||||
| May 10, 2017 | |||||||
| Mar 16, 2017 | |||||||
| Nov 9, 2016 | |||||||
| Aug 10, 2016 | |||||||
| May 11, 2016 | |||||||
| Mar 23, 2016 | |||||||
| Nov 12, 2015 | |||||||
| Aug 6, 2015 |